Olema Pharmaceuticals, Inc. Cash Flow Statement

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -22.12M
Share-based Compensation 3.11M15.91M18.83M17.26M22.58M
Gains from Investment Securities 0.10M0.70M0.30M3.50M3.30M
Cash from Operations -19.87M-50.69M-82.06M-83.73M-104.35M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 1.22M1.30M1.30M1.15M
Amortization of Deferred Charges 0.64M
Depreciation & Amortization (CF) 0.01M0.16M0.36M0.38M0.39M
Change in Working Capital
Change in Account Payables -0.22M-0.68M0.35M2.32M2.51M
Change in Accured Expenses 2.77M4.57M7.02M2.95M11.20M
Other Working Capital Changes 3.55M-0.99M1.96M-1.23M-1.16M
Investing Activities
Capital Expenditures 0.06M1.57M0.36M0.16M
Sales of Property, Plant and Equipment 0.01M
Change in Acquisitions & Divestments 213.10M305.50M250.76M301.59M
Cash from Investing Activities -0.06M-275.44M91.48M-4.85M-93.53M
Financing Activities
Cash from Financing Activities 358.40M1.39M0.48M133.41M268.82M
Additional items
Change in Cash 338.48M-324.74M9.89M44.84M70.94M
Free Cash Flow -19.92M-52.27M-82.43M-83.73M-104.51M
Net Cash Flow 338.48M-324.74M9.89M44.84M70.94M